Beijing Hotgen Biotech Co., Ltd. (688068.SS) SHH

234.30

+6.83(+3.00%)

Updated at August 19 11:29AM

Currency In CNY

Valuation

Market Cap5.71B
Enterprise Value5.44B
P/E Ratio-103.87
PEG Ratio6.3
Price/Sales Ratio44.51
Price/Book Ratio7.25
Enterprise/Revenue44.25
Enterprise/EBITDA-138.98

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-0.43
Operating Margin-0.41

Management Effectiveness

Return On Assets-0.06
Return On Equity-0.07

Income Statement

Revenue510.9M
Revenue/Share5.29
Gross Profit282.83M
EBITDA-96.66M
Net Income-179.23M
Diluted EPS-1.94

Balance Sheet

Total Cash737.7M
Total Cash/Share7.99
Total Debt50.12M
Total Debt/Equity0.02
Current Ratio5.37
Book Value Per Share32.3

Price History

52-Week Change751.07
52-Week High262.22
52-Week Low22.94
Moving Average 50 Days183.9
Moving Average 200 Days107.24

Statistics

Average Volume3.22M
Shares Outstanding92.71M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.08
Last Split Factor37:25
Last Split DateJune 16, 2022